Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of €7.38 billion as of September 26, 2025. Its market cap has increased by 7.97% in one year.

Market Cap

7.38B

Enterprise Value

8.22B

Revenue

1.00B

Ranking

n/a

PE Ratio

15.55

Stock Price

€63.32

Market Cap Chart

Since May 14, 2004, Halozyme Therapeutics's market cap has increased from 141.66M to 7.38B, an increase of 5,107.83%. That is a compound annual growth rate of 20.30%.

Market Cap History

Date	Market Cap	% Change
Sep 26, 2025	7.38B	25.56%
Dec 31, 2024	5.88B	33.01%
Dec 29, 2023	4.42B	-38.64%
Dec 30, 2022	7.20B	44.69%
Dec 31, 2021	4.98B	5.58%
Dec 31, 2020	4.71B	104.10%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
UniCredit	100.17B
Intesa Sanpaolo	95.51B
Enel SpA	80.83B
Ferrari	72.50B
Assicurazioni Generali	49.68B
Eni S.p.A.	45.83B
Leonardo S.p.a.	30.49B
Poste Italiane	25.79B

Market Cap Rankings